MADRID, 27 (CNMV) Bayer: Nexavar ® (sorafenib) Granted Priority Review for Differentiated Thyroid Cancer in the U.S.Información completa en: http://www.cnmv.es/portal/hr/HRAlDia.aspx?lang=es .